Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

1.

Phase II study of concurrent capecitabine and external beam radiotherapy for pain control of bone metastases of breast cancer origin.

Kundel Y, Nasser NJ, Purim O, Yerushalmi R, Fenig E, Pfeffer RM, Stemmer SM, Rizel S, Symon Z, Kaufman B, Sulkes A, Brenner B.

PLoS One. 2013 Jul 10;8(7):e68327. doi: 10.1371/journal.pone.0068327. Print 2013.

PMID:
23874586
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Radiation therapy in the management of symptomatic bone metastases: the effect of total dose and histology on pain relief and response duration.

Arcangeli G, Giovinazzo G, Saracino B, D'Angelo L, Giannarelli D, Arcangeli G, Micheli A.

Int J Radiat Oncol Biol Phys. 1998 Dec 1;42(5):1119-26.

PMID:
9869238
[PubMed - indexed for MEDLINE]
3.

Single versus multiple fractions of repeat radiation for painful bone metastases: a randomised, controlled, non-inferiority trial.

Chow E, van der Linden YM, Roos D, Hartsell WF, Hoskin P, Wu JS, Brundage MD, Nabid A, Tissing-Tan CJ, Oei B, Babington S, Demas WF, Wilson CF, Meyer RM, Chen BE, Wong RK.

Lancet Oncol. 2014 Feb;15(2):164-71. doi: 10.1016/S1470-2045(13)70556-4. Epub 2013 Dec 23.

PMID:
24369114
[PubMed - indexed for MEDLINE]
4.

A phase II trial of neoadjuvant capecitabine combined with hyperfractionated accelerated radiation therapy in locally advanced rectal cancer.

Marsh Rde W, George TJ, Siddiqui T, Mendenhall WM, Zlotecki RA, Grobmyer S, Hochwald S, Chang M, Larson B, King J.

Am J Clin Oncol. 2010 Jun;33(3):251-6. doi: 10.1097/COC.0b013e3181a650e8.

PMID:
19823074
[PubMed - indexed for MEDLINE]
5.

Palliative radiotherapy for painful bone metastases from solid tumors delivered with static ports of tomotherapy (TomoDirect): feasibility and clinical results.

Franco P, Migliaccio F, Angelini V, Cante D, Sciacero P, Peruzzo Cornetto A, Casanova Borca V, Zeverino M, Torielli P, Arrichiello C, Girelli G, La Porta MR, Tofani S, Numico G, Ricardi U.

Cancer Invest. 2014 Nov;32(9):458-63. doi: 10.3109/07357907.2014.958495. Epub 2014 Sep 26.

PMID:
25259607
[PubMed - indexed for MEDLINE]
6.

Simultaneous integrated boost-intensity modulated radiation therapy with concomitant capecitabine and mitomycin C for locally advanced anal carcinoma: a phase 1 study.

Deenen MJ, Dewit L, Boot H, Beijnen JH, Schellens JH, Cats A.

Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):e201-7. doi: 10.1016/j.ijrobp.2012.12.008.

PMID:
23517808
[PubMed - indexed for MEDLINE]
7.

Synchronous chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck using capecitabine: a single-centre, open-label, single-group phase II study.

Jegannathen A, Mais K, Sykes A, Lee L, Yap B, Birzgalis A, Homer J, Ryder WD, Slevin N.

Clin Oncol (R Coll Radiol). 2011 Mar;23(2):149-58. doi: 10.1016/j.clon.2010.09.010. Epub 2010 Oct 14.

PMID:
20951012
[PubMed - indexed for MEDLINE]
8.

Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases.

Hartsell WF, Scott CB, Bruner DW, Scarantino CW, Ivker RA, Roach M 3rd, Suh JH, Demas WF, Movsas B, Petersen IA, Konski AA, Cleeland CS, Janjan NA, DeSilvio M.

J Natl Cancer Inst. 2005 Jun 1;97(11):798-804.

PMID:
15928300
[PubMed - indexed for MEDLINE]
Free Article
9.

[Palliative radiotherapy of bone metastases. A retrospective analysis of 176 patients].

Koswig S, Buchali A, Böhmer D, Schlenger L, Budach V.

Strahlenther Onkol. 1999 Oct;175(10):509-14. Review. German.

PMID:
10554646
[PubMed - indexed for MEDLINE]
10.

Palliation of bone metastases: a survey of patterns of practice among Canadian radiation oncologists.

Chow E, Danjoux C, Wong R, Szumacher E, Franssen E, Fung K, Finkelstein J, Andersson L, Connolly R.

Radiother Oncol. 2000 Sep;56(3):305-14.

PMID:
10974379
[PubMed - indexed for MEDLINE]
11.

Capecitabine-based chemoradiotherapy with adjuvant capecitabine for locally advanced squamous carcinoma of the uterine cervix: phase II results.

Domingo E, Lorvidhaya V, de Los Reyes R, Syortin T, Kamnerdsupaphon P, Lertbutsayanukul C, Vito-Cruz E, Tharavichitkul E, Jin K, Yoshihara M, Cupino N, Lertsanguansinchai P.

Oncologist. 2009 Aug;14(8):828-34. doi: 10.1634/theoncologist.2009-0041. Epub 2009 Aug 6.

PMID:
19661184
[PubMed - indexed for MEDLINE]
Free Article
12.

Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: a validation phase II trial.

Arbea L, Martínez-Monge R, Díaz-González JA, Moreno M, Rodríguez J, Hernández JL, Sola JJ, Ramos LI, Subtil JC, Nuñez J, Chopitea A, Cambeiro M, Gaztañaga M, García-Foncillas J, Aristu J.

Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):587-93. doi: 10.1016/j.ijrobp.2011.06.2008. Epub 2011 Nov 11.

PMID:
22079731
[PubMed - indexed for MEDLINE]
13.

(188)Re-HEDP combined with capecitabine in hormone-refractory prostate cancer patients with bone metastases: a phase I safety and toxicity study.

Lam MG, Bosma TB, van Rijk PP, Zonnenberg BA.

Eur J Nucl Med Mol Imaging. 2009 Sep;36(9):1425-33. doi: 10.1007/s00259-009-1119-8. Epub 2009 Mar 25.

PMID:
19319526
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer.

Machiels JP, Sempoux C, Scalliet P, Coche JC, Humblet Y, Van Cutsem E, Kerger J, Canon JL, Peeters M, Aydin S, Laurent S, Kartheuser A, Coster B, Roels S, Daisne JF, Honhon B, Duck L, Kirkove C, Bonny MA, Haustermans K.

Ann Oncol. 2007 Apr;18(4):738-44. Epub 2007 Jan 5.

PMID:
17208931
[PubMed - indexed for MEDLINE]
Free Article
15.

Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer.

Ben-Josef E, Shields AF, Vaishampayan U, Vaitkevicius V, El-Rayes BF, McDermott P, Burmeister J, Bossenberger T, Philip PA.

Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):454-9.

PMID:
15145162
[PubMed - indexed for MEDLINE]
16.

Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study.

De Paoli A, Chiara S, Luppi G, Friso ML, Beretta GD, Del Prete S, Pasetto L, Santantonio M, Sarti E, Mantello G, Innocente R, Frustaci S, Corvò R, Rosso R.

Ann Oncol. 2006 Feb;17(2):246-51. Epub 2005 Nov 9.

PMID:
16282246
[PubMed - indexed for MEDLINE]
Free Article
17.

Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial.

Dunst J, Debus J, Rudat V, Wulf J, Budach W, Hoelscher T, Reese T, Mose S, Roedel C, Zuehlke H, Hinke A.

Strahlenther Onkol. 2008 Sep;184(9):450-6. doi: 10.1007/s00066-008-1751-4. Epub 2008 Sep 19.

PMID:
19016023
[PubMed - indexed for MEDLINE]
18.

Capecitabine: a review.

Walko CM, Lindley C.

Clin Ther. 2005 Jan;27(1):23-44. Review.

PMID:
15763604
[PubMed - indexed for MEDLINE]
19.

Pre-operative bevacizumab, capecitabine, oxaliplatin and radiation among patients with locally advanced or low rectal cancer: a phase II trial.

Kennecke H, Berry S, Wong R, Zhou C, Tankel K, Easaw J, Rao S, Post J, Hay J.

Eur J Cancer. 2012 Jan;48(1):37-45. doi: 10.1016/j.ejca.2011.05.016. Epub 2011 Jun 12.

PMID:
21664123
[PubMed - indexed for MEDLINE]
20.

Capecitabine in patients with breast cancer relapsing after high-dose chemotherapy plus autologous peripheral stem cell transplantation--a phase II study.

Jakob A, Bokemeyer C, Knop S, Schupp M, Mayer F, Kanz L.

Anticancer Drugs. 2002 Apr;13(4):405-10.

PMID:
11984086
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk